Direkt zum Inhalt
Merck

Fortfahren mit

03124-M

Kaliumiodid

puriss., meets analytical specification of Ph. Eur. BP, USP, 99.0-100.5% (calc. to the dried substance)

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern
PackungsgrößeSKUVerfügbarkeitPreis

Über diesen Artikel

Lineare Formel:
KI
CAS-Nummer:
Molekulargewicht:
166.00
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
12352302
EC Number:
231-659-4
MDL number:
Assay:
99.0-100.5% (calc. to the dried substance)
Form:
crystalline
Solubility:
water: complete (ca.1,430 g/l at 25 °C (77 °F))
Preise und Verfügbarkeit sind derzeit nicht verfügbar.
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten


vapor pressure

1 mmHg ( 745 °C)

grade

puriss.

assay

99.0-100.5% (calc. to the dried substance)

form

crystalline

quality

meets analytical specification of Ph. Eur. BP, USP

impurities

ammonium, in accordance, organic volatile impurities, complies (GC), residual solvents, in accordance, thiosulfate (S2O3), in accordance, ≤0.001% heavy metals (as Pb), ≤0.01% thiosulfate (S2O3), ≤0.02% free alkali (as KOH)

loss

≤0.5% loss on drying, 105 °C

pH

6-9 (25 °C, 166 g/L)

mp

681 °C (lit.)

solubility

water: complete (ca.1,430 g/l at 25 °C (77 °F))

anion traces

iodate (IO3-): in accordance, nitrate (NO3-): in accordance, nitrite (NO2-): in accordance, sulfate (SO42-): ≤0.01%

cation traces

Ba:, in accordance, Fe: ≤0.001%

suitability

complies for appearance of solution

SMILES string

[K+].[I-]

InChI

1S/HI.K/h1H;/q;+1/p-1

InChI key

NLKNQRATVPKPDG-UHFFFAOYSA-M

General description

Potassium iodide (KI) is an inorganic potassium salt. Alumina loaded with potassium iodide has been employed as catalyst for the transesterification of soybean oil with methanol. Influence of KI on the in vitro generation of polymorphonudear leukocyte (PMN)-derived oxygen intermediates has been investigated.[1]

Application

Potassium iodide (KI) was used in the preparation of standard iodide stock solution for the determination of iodide by size exclusion chromatography.[2] It may be used in the spectrophotometric determination of advanced oxidation protein products (AOPP).[3]

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 1

Dieser Artikel
30315-M793582746428
form

crystalline

form

crystalline

form

powder or crystals

form

crystals

solubility

water: complete (ca.1,430 g/l at 25 °C (77 °F))

solubility

water: complete (ca.1,430 g/l at 25 °C (77 °F))

solubility

water: complete (ca.1,430 g/l at 25 °C (77 °F))

solubility

water: complete (ca.1,430 g/l at 25 °C (77 °F))

assay

99.0-100.5% (calc. to the dried substance)

assay

≥99.0%, 99.0-100.5% (calc. to the dried substance)

assay

99%

assay

≥99%

grade

puriss.

grade

puriss. p.a.

grade

-

grade

-

mp

681 °C (lit.)

mp

681 °C (lit.)

mp

681 °C (lit.)

mp

681 °C (lit.)

vapor pressure

1 mmHg ( 745 °C)

vapor pressure

1 mmHg ( 745 °C)

vapor pressure

1 mmHg ( 745 °C)

vapor pressure

1 mmHg ( 745 °C)


Still not finding the right product?

Explore all of our products under Kaliumiodid


pictograms

Health hazard

signalword

Danger

hcodes

Hazard Classifications

STOT RE 1 Oral

target_organs

Thyroid

Lagerklasse

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen



Y Miyachi et al.
The British journal of dermatology, 107(2), 209-214 (1982-08-01)
The effects of potassium iodide, colchicine and dapsone on the in vitro generation of polymorphonuclear leukocyte (PMN)-derived oxygen intermediates were investigated. These three drugs have beneficial effects on those conditions in which PMNs play an important pathogenetic role. Three oxygen
V Witko-Sarsat et al.
Journal of immunology (Baltimore, Md. : 1950), 161(5), 2524-2532 (1998-09-02)
We previously demonstrated the presence of advanced oxidation protein products (AOPP), a novel marker of oxidative stress in the plasma of uremic patients receiving maintenance dialysis. The present study in a cohort of 162 uremic patients showed that plasma concentrations
H B Li et al.
Journal of chromatography. A, 918(2), 335-339 (2001-06-16)
A novel method for the determination of iodide by size exclusion chromatography was established. The method was simple and highly sensitive with good precision. Iodide was converted to iodine, then sequestered with starch, and separated from the matrix using a



Questions

Reviews

No rating value

Active Filters